Health Care & Life Sciences » Pharmaceuticals | Seoul Pharma Co. Ltd.

Seoul Pharma Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
618
696
783
817
881
Depreciation, Depletion & Amortization
2,480
2,477
3,785
2,983
2,537
Other Funds
74
-
-
83
14
Funds from Operations
4,469
3,261
2,991
7,173
7,257
Changes in Working Capital
4,895
1,783
1,569
9,063
8,394
Net Operating Cash Flow
425
1,478
1,421
1,890
1,137
Capital Expenditures
11,887
3,654
1,403
6,218
1,605
Sale of Fixed Assets & Businesses
-
-
4
2
6,714
Purchase/Sale of Investments
122
35
27
41
250
Net Investing Cash Flow
11,516
3,730
1,429
6,635
5,373
Cash Dividends Paid - Total
378
343
240
178
111
Issuance/Reduction of Debt, Net
2,311
6,349
2,249
8,982
9,421
Net Financing Cash Flow
8,859
6,006
5,465
8,887
9,546
Net Change in Cash
3,082
3,755
5,457
361
5,310
Free Cash Flow
10,962
1,142
297
7,966
2,572
Other Sources
346
72
-
222
14
Change in Capital Stock
7,000
-
3,456
-
-
Other Uses
97
117
-
600
-

About Seoul Pharma Co.

View Profile
Address
124-31 Osongsaengmyeong 6-ro
Cheongju NC 28158
Korea, Republic Of
Employees -
Website http://www.seoulpharma.com
Updated 09/14/2018
Seoul Pharma Co., Ltd. engages in the manufacturing and distribution of pharmaceuticals. Its products include drugs for cardiovascular system, respiratory and digestive system, antipyretic, analgesic, anti-inflammatory, antibacterial, anti-fungal, anti-viral, cream and ointment, anti-diabetic, anti-obesity, tonics, vitamins and minerals. The company was founded in 1976 and is headquartered in Cheongju, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.